Primary sclerosing cholangitis is a rare liver complication that can develop among people with inflammatory bowel disease. Early diagnosis can help, but there’s no cure.

Ahead of New York Fashion Week, Gilead Sciences is strutting its marketing stuff to raise awareness of primary biliary ...

Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today announced its decision to voluntarily withdraw OCALIVA® (obeticholic acid) from the US market ...

Intercept Pharmaceuticals has voluntarily removed Ocaliva from the United States market for the treatment of primary biliary ...

Intercept Pharmaceuticals withdraws Ocaliva from the U.S. market following FDA concerns over safety and effectiveness for ...

Internal medicine and rheumatology specialist Siobhan Deshauer, MD, delves into a medical mystery triggered by a puffed bean ...

A FORMER Premier League goalkeeper has been diagnosed with two terminal illnesses and is now receiving palliative care. Russell Hoult’s family confirmed the ex-Derby County and West ...

A simplified one-dose antibiotic treatment is found to be as effective as the standard three-dose regimen for early syphilis.

Mirum Pharmaceuticals, Inc. ( NASDAQ: MIRM) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 8:30 AM EDT ...